These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

164 related articles for article (PubMed ID: 29794412)

  • 41. Cost-effectiveness of Low-density Lipoprotein Cholesterol Level-Guided Statin Treatment in Patients With Borderline Cardiovascular Risk.
    Kohli-Lynch CN; Bellows BK; Thanassoulis G; Zhang Y; Pletcher MJ; Vittinghoff E; Pencina MJ; Kazi D; Sniderman AD; Moran AE
    JAMA Cardiol; 2019 Oct; 4(10):969-977. PubMed ID: 31461121
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Triglyceride-Rich Lipoprotein Cholesterol and Risk of Cardiovascular Events Among Patients Receiving Statin Therapy in the TNT Trial.
    Vallejo-Vaz AJ; Fayyad R; Boekholdt SM; Hovingh GK; Kastelein JJ; Melamed S; Barter P; Waters DD; Ray KK
    Circulation; 2018 Aug; 138(8):770-781. PubMed ID: 29618599
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Atherogenic Lipoprotein Subfractions Determined by Ion Mobility and First Cardiovascular Events After Random Allocation to High-Intensity Statin or Placebo: The Justification for the Use of Statins in Prevention: An Intervention Trial Evaluating Rosuvastatin (JUPITER) Trial.
    Mora S; Caulfield MP; Wohlgemuth J; Chen Z; Superko HR; Rowland CM; Glynn RJ; Ridker PM; Krauss RM
    Circulation; 2015 Dec; 132(23):2220-9. PubMed ID: 26408274
    [TBL] [Abstract][Full Text] [Related]  

  • 44. HDL-C: role as a risk modifier.
    Barter P
    Atheroscler Suppl; 2011 Nov; 12(3):267-70. PubMed ID: 22152280
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Comparison of Low-Density Lipoprotein Cholesterol Concentrations by Direct Measurement and by Friedewald Calculation.
    Sung KC; Kwon CH; Lee MY; Kwon MJ; Lee JH; Jung MH; Shin JH
    Am J Cardiol; 2020 Mar; 125(6):866-873. PubMed ID: 31928718
    [TBL] [Abstract][Full Text] [Related]  

  • 46. An improved method for estimating low LDL-C based on the enhanced Sampson-NIH equation.
    Coverdell TC; Sampson M; Zubirán R; Wolska A; Donato LJ; Meeusen JW; Jaffe AS; Remaley AT
    Lipids Health Dis; 2024 Feb; 23(1):43. PubMed ID: 38331834
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Correlation of extended Martin/Hopkins equation with a direct homogeneous assay in assessing low-density lipoprotein cholesterol in patients with hypertriglyceridemia.
    Chung S
    J Clin Lab Anal; 2023 Sep; 37(17-18):e24963. PubMed ID: 37679962
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Low-Density Lipoprotein Cholesterol, Non-High-Density Lipoprotein Cholesterol, Triglycerides, and Apolipoprotein B and Cardiovascular Risk in Patients With Manifest Arterial Disease.
    van den Berg MJ; van der Graaf Y; de Borst GJ; Kappelle LJ; Nathoe HM; Visseren FLJ;
    Am J Cardiol; 2016 Sep; 118(6):804-810. PubMed ID: 27471056
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Performance of LDL-C calculated with Martin's formula compared to the Friedewald equation in familial combined hyperlipidemia.
    Mehta R; Reyes-Rodríguez E; Yaxmehen Bello-Chavolla O; Guerrero-Díaz AC; Vargas-Vázquez A; Cruz-Bautista I; A Aguilar-Salinas C
    Atherosclerosis; 2018 Oct; 277():204-210. PubMed ID: 29970255
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Comparative prognostic value of low-density lipoprotein cholesterol and C-reactive protein in patients with stable coronary artery disease treated with percutaneous coronary intervention and chronic statin therapy.
    Ndrepepa G; Braun S; Tada T; Guerra E; Schunkert H; Laugwitz KL; Kastrati A
    Cardiovasc Revasc Med; 2014 Apr; 15(3):131-6. PubMed ID: 24630704
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Risk factors affecting the failed low-density lipoprotein level achievement rate in working-age male population at high cardiovascular risk.
    Momo K; Yasu T; Yasui H; Kuroda SI
    J Clin Pharm Ther; 2019 Oct; 44(5):715-719. PubMed ID: 31062402
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Applicability of Martin-Hopkins formula and comparison with Friedewald formula for estimated low-density lipoprotein cholesterol in e_COR study population.
    Ferrinho C; Alves AC; Bourbon M; Duarte S
    Rev Port Cardiol (Engl Ed); 2021 Aug; ():. PubMed ID: 34389206
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Estimation of low-density lipoprotein cholesterol levels using machine learning.
    Oh GC; Ko T; Kim JH; Lee MH; Choi SW; Bae YS; Kim KH; Lee HY
    Int J Cardiol; 2022 Apr; 352():144-149. PubMed ID: 35065153
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Low-density lipoprotein cholesterol levels and lipid-modifying therapy prescription patterns in the real world: An analysis of more than 33,000 high cardiovascular risk patients in Japan.
    Teramoto T; Uno K; Miyoshi I; Khan I; Gorcyca K; Sanchez RJ; Yoshida S; Mawatari K; Masaki T; Arai H; Yamashita S
    Atherosclerosis; 2016 Aug; 251():248-254. PubMed ID: 27419905
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Non-HDL Cholesterol is a More Superior Predictor of Small-Dense LDL Cholesterol than LDL Cholesterol in Japanese Subjects with TG Levels ＜400 mg/dL.
    Moriyama K; Takahashi E
    J Atheroscler Thromb; 2016 Sep; 23(9):1126-37. PubMed ID: 27001003
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Elevated Serum Non-HDL (High-Density Lipoprotein) Cholesterol and Triglyceride Levels as Residual Risks for Myocardial Infarction Recurrence Under Statin Treatment.
    Suzuki K; Oikawa T; Nochioka K; Miura M; Kasahara S; Sato M; Aoyanagi H; Shiroto T; Takahashi J; Miyata S; Sakata Y; Shimokawa H
    Arterioscler Thromb Vasc Biol; 2019 May; 39(5):934-944. PubMed ID: 30866657
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Comparison of the accuracy of the Friedewald, Martin, and Sampson formulas to estimate very low levels of low-density lipoprotein cholesterol.
    Benido Silva V; Chaves C; Oliveira JC; Palma I
    Endokrynol Pol; 2023; 74(2):203-210. PubMed ID: 37155302
    [TBL] [Abstract][Full Text] [Related]  

  • 58. High-Intensity Versus Non-High-Intensity Statins in Patients Achieving Low-Density Lipoprotein Cholesterol Goal After Percutaneous Coronary Intervention.
    Kim J; Park KT; Jang MJ; Park TK; Lee JM; Yang JH; Song YB; Choi SH; Gwon HC; Lee SH; Hong KP; Hahn JY
    J Am Heart Assoc; 2018 Nov; 7(21):e009517. PubMed ID: 30376751
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Clinical Efficacy and Safety of Evolocumab in High-Risk Patients Receiving a Statin: Secondary Analysis of Patients With Low LDL Cholesterol Levels and in Those Already Receiving a Maximal-Potency Statin in a Randomized Clinical Trial.
    Giugliano RP; Keech A; Murphy SA; Huber K; Tokgozoglu SL; Lewis BS; Ferreira J; Pineda AL; Somaratne R; Sever PS; Pedersen TR; Sabatine MS
    JAMA Cardiol; 2017 Dec; 2(12):1385-1391. PubMed ID: 29117276
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Intensive statin therapy for Indians: Part-I. Benefits.
    Enas EA; Pazhoor HC; Kuruvila A; Vijayaraghavan K
    Indian Heart J; 2011; 63(3):211-27. PubMed ID: 22734339
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.